Zheng Xing Xing Ye Ri Bao·2025-11-13 08:44Market Overview - The pharmaceutical commercial sector rose by 0.17% on November 13, with HeFu China leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Stock Performance - HeFu China (603122) closed at 22.10, with a 10.00% increase and a trading volume of 483,300 shares, amounting to a transaction value of 1.052 billion [1] - Renmin Tongtai (600829) also saw a 10.00% increase, closing at 13.75 with a trading volume of 69,400 shares [1] - Other notable performers included Yao Yi Gou (300937) with a 3.13% increase, closing at 36.21, and Bihe Pharmaceutical (002788) with a 2.51% increase, closing at 10.63 [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 269 million from institutional investors, while retail investors saw a net inflow of 305 million [2] - Notable stocks with significant capital flow included Jia Shi Tang (002462) with a net inflow of 20.71 million from institutional investors [2] - Daclin (603233) had a net outflow of 11.60 million from retail investors, indicating mixed investor sentiment [2]